Cefaclor

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Half-lifeThis section has been translated automatically.

0,5–1 h

Spectrum of actionThis section has been translated automatically.

Citrobacter diversus, Enterobacter sakazakii, E. coli, Haemophilus influenzae, Klebsiella spp., Moraxella catarrhalis, Neisseria gonorrhoeae, Plesiomonasshigelloides, Proteus mirabilis, Salmonella spp.

IndicationThis section has been translated automatically.

Respiratory and urinary tract infections, uncomplicated gonorrhoea, skin and soft tissue infections.

Dosage and method of useThis section has been translated automatically.

  • Adults: 3 times/day 500-1000 mg p.o.
  • Children: 30-50 mg/kg bw/day (for children < 6 years the daily dose must not exceed 1 g!)

PreparationsThis section has been translated automatically.

Cefaclor, Cefaclor-ratiopharm, Cefa-Wolff, Infectocef, Panoral

Authors

Last updated on: 29.10.2020